Creo Medical, emerging leader in electrosurgery, closes $8.45m in new financing round.
Creo Medical, an emerging leader in electrosurgery, today
announced the completion of its latest financing round totaling
$8.45m, including new investor Pentax Medical (HOYA Group).
Participants in this financing round also include existing
investors Finance Wales, the Angel CoFund and individual angel
investors. To date, Creo Medical has secured investment totaling
Described as ‘the first new electrosurgical platform in a
generation’ the Creo Medical CROMA energy system provides a unique
combination of super high frequency microwave energy for controlled
coagulation and bipolar radiofrequency energy for precise soft
tissue cutting, supporting a wide range of surgical instruments for
applications such as therapeutic endoscopy, laparoscopic surgery
and tumor ablation.
“We welcome our new investor Pentax Medical, identifying
therapeutic endoscopy as a priority area they support Creo
Medical’s vision to be leaders in electrosurgery. With this latest
investment we are well positioned to complete US regulatory
approval, build on our growing intellectual property portfolio and
develop commercial traction in key global markets.” commented Craig
Gulliford, CEO, Creo Medical
David Woods, Chief Marketing Officer, Pentax Medical remarked
“We are pleased to be investing in an organization with a proven
record of innovation in a business that aligns seamlessly with
Pentax Medical’s cutting-edge flexible endoscopes portfolio. This
investment grants us access to an innovative electrosurgical
platform and accelerates Pentax Medical’s strategy of more
effectively serving physicians and their patients in a rapidly
evolving healthcare industry by expanding into the vital endoscopic
Dr Richard Thompson, from Finance Wales’ technology ventures
team added, “Finance Wales is a long-term backer of Creo Medical,
this being the latest in a number of investments. We are pleased to
see the company making impressive progress."
Creo Medical’s technology platform supports the continuing
evolution of advanced therapeutic endoscopy and other minimally
invasive surgical techniques, driving improved outcomes for
patients and reducing costs to healthcare providers.